Pregnancy after in vitro fertilization: obstetric and perinatal risks
- Авторлар: Igitova M.B.1, Kazanina A.B.1, Cherkasova T.M.1, Yavorskaya S.D.1, Dmitrienko K.V.1, Dolgova N.S.1
-
Мекемелер:
- Altay State Medical University, Ministry of Health of the Russian Federation
- Шығарылым: № 7 (2024)
- Беттер: 58-64
- Бөлім: Original Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/635283
- DOI: https://doi.org/10.18565/aig.2024.94
- ID: 635283
Дәйексөз келтіру
Аннотация
Relevance: The incidence of infertile marriages in Russia is steadily increasing, as is the rate of pregnancies after assisted reproductive technologies (ART). However, obstetric and perinatal outcomes of patients undergoing ART have not been fully studied.
Objective: To evaluate the incidence and structure of obstetric and perinatal complications in pregnant women following in vitro fertilization (IVF).
Materials and methods: Obstetric and perinatal outcomes were retrospectively analyzed in 96 patients with singleton pregnancies resulting from IVF (study group) and in 96 patients with spontaneous pregnancy (control group), who were matched by age, parity, and other characteristics.
Results: The incidence of major pregnancy complications in the control group was not significantly different from that in the study group. However, the study group had a significantly higher incidence of anemia (54/96 (56.3%) vs. 24/96 (25.0%); p<0.001) and gestational diabetes mellitus (26/96 (27.1%) vs. 11/96 (11.5%); p=0.01), as well as uteroplacental blood flow abnormalities in the third trimester of pregnancy and before delivery (40/96 (41.7%) vs. 25/96 (26.0%); p=0.03). The majority of patients in the study group underwent cesarean section (71/96 (74.0%) vs. 25/96 (26.0%), respectively; p<0.001). In study group planned surgeries were more common than emergency surgeries (60/71 (84.5%) vs. 9/25 (36.0%), respectively; p<0.001). Opposite dynamics were observed in the control group. Newborns from mothers in the study group were eight times more likely to have septal heart defects (15/96 (15.6%) versus 2/96 (2.1%); p>0.05) and were six times more likely to have transient hypoglycemia (19/96 (19.8%) vs. 3/96 (3.1%); p>0.05). They were also 2 times more likely to require a second stage of nursing (7/96 (7.3%) vs. 3/96 (3.1%); p>0.05).
Conclusion: The identified features of the course of pregnancy and the condition of newborns in patients who became pregnant as a result of IVF indicate that pregnancy in this group of patients should be managed by highly qualified obstetrician-gynecologists. When planning childbirth, it is necessary to assess the risks and choose the optimal method of delivery and a maternity facility where there is a possibility of early neonatal diagnosis of congenital malformations and provision of prolonged postnatal care to newborns.
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Marina Igitova
Altay State Medical University, Ministry of Health of the Russian Federation
Email: Igitova-2011@mail.ru
ORCID iD: 0000-0003-1267-4179
Dr. Med. Sci., Professor, Department of Obstetrics and Gynecology
Ресей, BarnaulAnastasia Kazanina
Altay State Medical University, Ministry of Health of the Russian Federation
Email: asia_kor@mail.ru
ORCID iD: 0009-0006-2320-4964
Teaching Assistant at the Department of Neonatology and Pediatric Anesthesiology
Ресей, BarnaulTatiana Cherkasova
Altay State Medical University, Ministry of Health of the Russian Federation
Email: tanechka.cherkasova.2013@mail.ru
ORCID iD: 0000-0001-6841-7134
PhD, Associate Professor at the Department of Neonatology and Pediatric Anesthesiology
Ресей, BarnaulSvetlana Yavorskaya
Altay State Medical University, Ministry of Health of the Russian Federation
Email: L2001@bk.ru
ORCID iD: 0000-0001-6362-5700
Dr. Med. Sci., Professor at the Department of Obstetrics and Gynecology, Altay State Medical University, Ministry of Health of the Russian Federation
Ресей, BarnaulKsenia Dmitrienko
Altay State Medical University, Ministry of Health of the Russian Federation
Хат алмасуға жауапты Автор.
Email: tishovakseni@mail.ru
ORCID iD: 0000-0003-0886-4471
PhD, Associate Professor at the Department of Obstetrics and Gynecology
Ресей, BarnaulNadezhda Dolgova
Altay State Medical University, Ministry of Health of the Russian Federation
Email: dolgovans@yandex.ru
ORCID iD: 0000-0002-3646-6596
PhD, Teaching Assistant at the Department of Obstetrics and Gynecology
Ресей, BarnaulӘдебиет тізімі
- Министерство здравоохранения Российской Федерации. Клинические рекомендации. Женское бесплодие. 2021. 81с. [Ministry of Health of the Russian Federation. Clinical guidelines. Female infertility. 2021. 81p. (in Russian)].
- Гурьева В.А. Распространенность и причины женского бесплодия в сельской и городской местности. В кн.: Академическая наука - проблемы и достижения. Материалы III международной научно-практической конференции. Том 1. 2014: 38. [Gur’eva V.A. Prevalence and causes of female infertility in rural and urban areas. In: Academic science - problems and achievements. Materials of the III International scientific and practical conference. Vol. 1. 2014: 38. (in Russian)].
- Жук Т.В., Яворская С.Д., Востриков В.В. Предикторы неудач программы ЭКО у пациенток с бесплодием и профицитом массы тела. Бюллетень медицинской науки. 2017; 3(7): 58-9. [Zhuk T.V., Yavorskaya S.D., Vostrikov V.V. IVF program failure predictors in patients with infertility and underweight. Bulletin of Medical Science. 2017; 3(7): 58-9. (in Russian)].
- Фазлыева Э.А., Галиева Г.А., Измайлова Р.А. Анализ рынка вспомогательных репродуктивных технологий в Российской Федерации и Республике Башкортостан. Менеджер здравоохранения. 2022; 3: 10-6. [Fazlyeva E.A., Galieva G.A., Izmailova R.A. Market analysis of assisted reproductive technologies in the Russian Federation and in the Republic of Bashkortostan. Manager Zdravoohranenia. 2022; (3): 10-6. (in Russian)]. https:// dx.doi.org/10.21045/1811-0185-2022-3-10-16.
- Яковлева О.В., Глухова Т.Н., Рогожина И.Е. Основные принципы ведения беременности после вспомогательных репродуктивных технологий. Медицинский вестник Северного Кавказа. 2020; 15(1): 140-5. [Yakovleva O.V., Glukhova T.N., Rogozhina I.E. Basic principles for the management of pregnancy after assisted reproductive technologies. Medical News of North Caucasus. 2020; 15(1): 140-5. (in Russian)]. https:// dx.doi.org/10.14300/mnnc.2020.15035.
- Wei D., Liu J.Y., Sun Y., Shi Y., Zhang B., Liu J.Q. et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet. 2019; 393(10178): 1310-8. https://dx.doi.org/10.1016/S0140-6736(18)32843-5.
- Министерство здравоохранения Российской Федерации. Клинические рекомендации. Нормальная беременность. 2023. [Ministry of Health of the Russian Federation. Clinical guidelines. Normal pregnancy. 2023. (in Russian)].
- Медик В.А., Толмачев М.С. Математическая статистика в медицине. 2-е изд. Том 1. М.: Издательство Юрайт; 2024. 472с. [Medik V.A., Tolmachev M.S. Mathematical statistics in medicine. 2nd ed. Vol. 1. Moscow: Yurait Publishing House; 2024. 472p. (in Russian)].
- American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice; Committee on Genetics; U.S. Food and Drug Administration. Committee Opinion No 671: perinatal risks associated with assisted reproductive technology. Obstet. Gynecol. 2016; 128(3): e61-e68. https://dx.doi.org/10.1097/AOG.0000000000001643.
- Lang M., Zhou M., Lei R., Li W. Comparison of pregnancy outcomes between IVF-ET pregnancies and spontaneous pregnancies in women of advanced maternal age. J. Matern. Fetal Neonatal Med. 2023. 36(1): 2183761. https://dx.doi.org/10.1080/14767058.2023.2183761.
- Alemdaroğlu S., Yılmaz Baran Ş., Durdağ G.D., Yuksel Şimşek S., Yetkinel S., Alkaş Yağınç D. et al. Intrahepatic cholestasis of pregnancy: are in vitro fertilization pregnancies at risk? J. Matern. Fetal Neonatal Med. 2021; 34(15): 2548-53. https://dx.doi.org/10.1080/ 14767058.2020.1765331.
- Ageheim M., Skalkidou A., Bergman E., Iliadis S., Lampa E., Lindström L. et al. Fetal growth after fresh and frozen embryo transfer and natural conception: a population-based register study. BJOG. 2024; 131(9): 1229-37. https://dx.doi.org/10.1111/1471-0528.17786.
- Cavoretto P., Candiani M., Giorgione V., Inversetti A., Abu-Saba M.M., Tiberio F. et al. Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF/ICSI treatment: meta-analysis of cohort studies. Ultrasound Obstet. Gynecol. 2018; 51(1): 43-53. https://dx.doi.org/10.1002/ uog.18930.
- Cavoretto P.I., Giorgione V., Sotiriadis A., Viganò P., Papaleo E., Galdini A. et al. IVF/ICSI treatment and the risk of iatrogenic preterm birth in singleton pregnancies: systematic review and meta-analysis of cohort studies. J. Matern. Fetal Neonatal Med. 2022; 35(10): 1987-96. https://dx.doi.org/10.1080/ 14767058.2020.1771690.
- Vermey B.G., Buchanan A., Chambers G.M., Kolibianakis E.M., Bosdou J., Chapman M.G. et al. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. BJOG. 2019; 126(2): 209-18. https://dx.doi.org/10.1111/ 1471-0528.15227.
- Romundstad L.B., Romundstad P.R., Sunde A., von Düring V., Skjaerven R., Vatten L.J. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum. Reprod. 2006; 21(9): 2353-8. https://dx.doi.org/10.1093/humrep/ del153.
- Heshmatnia F., Jafari M., Bozorgian L., Yadollahi P., Khalajinia Z., Azizi M. Is there a relationship between assisted reproductive technology and maternal outcomes? A systematic review of cohort studies. Int. J. Reprod. Biomed. 2023; 21(11): 861-80. https://dx.doi.org/10.18502/ijrm.v21i11.14651.
- Liu C.N., Yu F.B., Xu Y.Z., Li J.S., Guan Z.H., Sun M.N. et al. Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study. BMC Pregnancy Childbirth. 2021; 21(1): 332. https://dx.doi.org/10.1186/ s12884-021-03818-1.
- Johnson K.M., Hacker M.R., Thornton K., Young B.C., Modest A.M. Association between in vitro fertilization and ischemic placental disease by gestational age. Fertil. Steril. 2020; 114(3): 579-86. https://dx.doi.org/10.1016/ j.fertnstert.2020.04.029.
- Modest A.M., Johnson K.M., Karumanchi S.A., Resetkova N., Young B.C., Fox M.P. et al. Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study. J. Assist. Reprod. Genet. 2019; 36(9): 1917-26. https://dx.doi.org/10.1007/ s10815-019-01545-3.
- Richmond E., Ray J.G., Pudwell J., Djerboua M., Gaudet L., Walker M. et al. Caesarean birth in women with infertility: population-based cohort study. BJOG. 2022; 129(6): 908-16. https://dx.doi.org/10.1111/1471-0528.17019.
- Bay B., Boie S., Kesmodel U.S. Risk of stillbirth in low-risk singleton term pregnancies following fertility treatment: a national cohort study. BJOG. 2019; 126(2): 253-60. https://dx.doi.org/10.1111/ 1471-0528.15509.
- Sarmon K.G., Eliasen T., Knudsen U.B., Bay B. Assisted reproductive technologies and the risk of stillbirth in singleton pregnancies: a systematic review and meta-analysis. Fertil. Steril. 2021; 116(3): 784-92. https://dx.doi.org/10.1016/ j.fertnstert.2021.04.007.
- Chughtai A.A., Wang A.Y., Hilder L., Li Z., Lui K., Farquhar C. et al. Gestational age-specific perinatal mortality rates for assisted reproductive technology (ART) and other births. Hum. Reprod. 2018; 33(2): 320-7. https://dx.doi.org/10.1093/humrep/dex340.
- Sabban H., Zakhari A., Patenaude V., Tulandi T., Abenhaim H.A. Obstetrical and perinatal morbidity and mortality among in-vitro fertilization pregnancies: a population-based study. Arch. Gynecol. Obstet. 2017; 296(1): 107-13. https://dx.doi.org/10.1007/s00404-017-4379-8.
- Ombelet W., Van Blerkom J. , Bruckers L., Dhont N., Nargund G., Campo R. Promising perinatal outcome after using a simplified low-cost IVF culture system specifically designed for resource-poor countries. J. Clin. Med. 2023; 12(6): 2264. https://dx.doi.org/10.3390/jcm12062264.
- Parizot E., Dard R., Janel N., Vialard F. Down syndrome and infertility: what support should we provide? J. Assist. Reprod. Genet. 2019; 36(6): 1063-7. https://dx.doi.org/10.1007/s10815-019-01457-2.
- Wen S.W., Miao Q., Taljaard M., Lougheed J., Gaudet L., Davies M. et al. Associations of assisted reproductive technology and twin pregnancy with risk of congenital heart defects. JAMA Pediatr. 2020; 174(5): 446-54. https://dx.doi.org/10.1001/jamapediatrics.2019.6096.
- Sung N., Khan S.A., Yiu M.E., Jubiz G., Salazar M.D., Skariah A. et al. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment. J. Reprod. Immunol. 2021; 148: 103369. https://dx.doi.org/10.1016/ j.jri.2021.103369.
Қосымша файлдар
![](/img/style/loading.gif)